ciprofloxacin has been researched along with Dysentery, Shiga bacillus in 100 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 9.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| " coli was the predominant cause of travelers' diarrhea, loperamide combined with ciprofloxacin was not better than treatment with ciprofloxacin alone." | 9.07 | Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. ( Candler, W; Echeverria, P; McQueen, C; Sanchez, JL; Taylor, DN; Thornton, S, 1991) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 9.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 9.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 5.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| " coli was the predominant cause of travelers' diarrhea, loperamide combined with ciprofloxacin was not better than treatment with ciprofloxacin alone." | 5.07 | Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. ( Candler, W; Echeverria, P; McQueen, C; Sanchez, JL; Taylor, DN; Thornton, S, 1991) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 5.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| "Loperamide decreases the number of unformed stools and shortens the duration of diarrhea in dysentery caused by Shigella in adults treated with ciprofloxacin." | 5.07 | Ciprofloxacin and loperamide in the treatment of bacillary dysentery. ( Bodhidatta, L; Echeverria, P; Hoge, CW; Imlarp, S; Murphy, GS; Tamura, K; Tansuphaswadikul, S, 1993) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "From June 1985 to September 1987, 202 adults were enrolled in a randomized, double-blinded study comparing ciprofloxacin (500 mg) with sulfamethoxazole and trimethoprim (160 mg/800 mg) or placebo for adults with acute diarrhea." | 5.06 | Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. ( Goodman, LJ; Hines, D; Kaplan, RL; Landau, W; Mayer, KW; Nelson, JA; Parkhurst, GW; Petrak, R; Segreti, J; Trenholme, GM, 1990) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 5.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years." | 4.86 | Antibiotics for the treatment of dysentery in children. ( Black, RE; Munos, M; Traa, BS; Walker, CL, 2010) |
| "Ciprofloxacin, ceftriaxone, and sulfamethoxazole/trimethoprim are suitable choices for the treatment of bacterial acute diarrhea." | 3.83 | Characteristics of bacterial acute diarrhea among women. ( Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA, 2016) |
| "Detection of Shigella organisms and enteroinvasive Escherichia coli (EIEC) by polymerase chain reaction (PCR) was evaluated in 20 patients with dysentery before and in 17 of the 20 after treatment with ciprofloxacin." | 3.68 | Detection of Shigellae and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery. ( Eampokalap, B; Echeverria, P; Hoge, CW; Murphy, GS; Sethabutr, O; Venkatesan, M, 1993) |
| "In this study twice daily ciprofloxacin for 3 days achieved clinical cure rates similar to those for the same dosage given for 5 days in children with Sd1 dysentery." | 2.70 | Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. ( , 2002) |
| "Treatment of shigellosis is currently limited by the high prevalence of multidrug-resistant strains of Shigella." | 2.68 | Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. ( Bennish, ML; Dhar, U; Khan, WA; Salam, MA; Seas, C, 1997) |
| "Ciprofloxacin-treated patients had a mean of 29 stools during the study, compared with 46 for ampicillin-treated patients (P = ." | 2.67 | Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. ( Barza, M; Bennish, ML; Haider, R; Salam, MA, 1990) |
| "In a word, both drugs are effective in treating bacterial infections of digestive system, urinary system and respiratory tract." | 2.67 | [Clinical efficacy of ciprofloxacin and ofloxacin]. ( Jiang, SC; Miao, JZ; Wang, XF, 1994) |
| "A high prevalence of shigellosis continues in sub-Saharan Africa." | 1.91 | Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. ( Antonio, M; Awuor, AO; Badji, H; Doh, S; Focht, C; Hossain, MJ; Houpt, E; Jones, J; Jones, JCM; Juma, J; Kasumba, IN; Kotloff, KL; Liu, J; Nasrin, D; Nasrin, S; Ochieng, JB; Omore, R; Permala-Booth, J; Platts-Mills, JA; Powell, H; Roose, A; Sen, S; Sow, SO; Sugerman, CE; Tennant, SM; Verani, JR; Watson, N; Widdowson, MA; Zaman, SMA, 2023) |
| "Antimicrobial resistance against shigellosis is increasingly alarming." | 1.72 | Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh. ( Ahmed, D; Ahmed, T; Alam, B; Chakraborty, S; Chisti, MJ; Das, R; Das, S; Faruque, ASG; Haque, MA; Islam, SB; Khan, SH; Nuzhat, S; Palit, P, 2022) |
| "Shigellosis was induced by intraperitoneal administration of Shigella flexneri to immunodepressed mice pretreated with streptomycin." | 1.62 | Antibacterial and antishigellosis activity of Xylopia staudtii (engl. & diels), Annonaceae. ( Dimo, T; Donji Kenne Foweda, L; Dzeufiet Djomeni, PD; Fekam Boyom, F; Gounoue Kamkumo, R; Kouam Fogue, S; Lenta Ndjakou, B; Longo, F; Njonte Wouamba, SC; Pouofo Nguiam, M; Sewald, N, 2021) |
| "In high-income countries, shigellosis is mainly found in travellers to high-risk regions or in men who have sex with men (MSM)." | 1.62 | Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019. ( Alberny, M; Armas, M; Barberà, MJ; Cornejo-Sánchez, T; Espinal, P; Fàbrega, A; González-López, JJ; Goterris, L; Larrosa, MN; Martín-González, H; Mir-Cros, A; Moreno-Mingorance, A; Pumarola, T; Raventós, A; Rodriguez, V; Serra-Pladevall, J; Viñado, B, 2021) |
| "In the battle against shigellosis and other bacterial diseases, antibiotic resistance has become an increasing global public health threat." | 1.48 | Genomic Analysis and Resistance Mechanisms in Shigella flexneri 2a Strain 301. ( Cheng, F; Li, B; Wang, S; Zhang, J; Zhou, X; Zhu, Z, 2018) |
| "Cross-sectional analysis of all shigellosis cases (160) notified to public health authorities in NSW, Australia was performed." | 1.46 | Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints. ( Brown, JD; Franklin, N; Hazelton, B; Howard, P; O'Sullivan, M; Reinten, T; Sheppeard, V; Willcox, SJ, 2017) |
| "The treatment of shigellosis mostly requires antibiotics." | 1.46 | Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production. ( Dhital, S; Kattel, HP; Khadka, S; Khatiwada, S; Mishra, SK; Parajuli, K; Pokharel, BM; Rijal, B; Sharma, S; Sherchand, JB, 2017) |
| "Ciprofloxacin is a recommended treatment for Shigella infections." | 1.43 | South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant Shigella sonnei: A Cross-Sectional Study. ( Baker, S; Bodhidatta, L; Chung The, H; Cormican, M; De Lappe, N; Ha Thanh, T; Holt, KE; Howden, BP; Mason, CJ; Nguyen Thi Nguyen, T; Pham Thanh, D; Phu Huong Lan, N; Rabaa, MA; Sar, P; Thompson, CN; Thomson, NR; Thwaites, G; Turner, P; Valcanis, M; Voong Vinh, P; Vu Thuy, D; Wangchuk, S, 2016) |
| "Infection and diagnosis of shigellosis in MSM presents a potentially overlooked opportunity to discuss the availability of pre-exposure prophylaxis medications to prevent incident HIV infections." | 1.43 | Shigellosis in men who have sex with men: an overlooked opportunity to counsel with pre-exposure prophylaxis for HIV. ( Goulart, MA; Wurcel, AG, 2016) |
| "Shigellosis was associated with a syphilis report within 12 months (adjusted odds ratio (aOR) 8." | 1.43 | The worldwide spread of ciprofloxacin-resistant Shigella sonnei among HIV-infected men who have sex with men, Taiwan. ( Chen, WC; Chiou, CS; Izumiya, H; Kawamura, M; Liao, YS; Lo, YC; Su, YS; Wu, HH, 2016) |
| "Repeated outbreaks of locally acquired shigellosis among men who have sex with men highlight the importance of prevention and control measures in this high-risk group." | 1.43 | Travel Destinations and Sexual Behavior as Indicators of Antibiotic Resistant Shigella Strains--Victoria, Australia. ( Kirk, M; Lalor, K; Lane, CR; Stephens, N; Sutton, B; Valcanis, M; Walker, C, 2016) |
| "Shigellosis is a significant cause of morbidity and mortality worldwide, most notably amongst children." | 1.42 | Isolation and development of bioluminescent reporter phages for bacterial dysentery. ( Molineux, IJ; Schofield, DA; Wray, DJ, 2015) |
| "The proven shigellosis as well as the strong suspicion have to be treated promptly with antibiotics, mainly azithromycin." | 1.35 | [Bacterial diarrheas and antibiotics: European recommendations]. ( Cohen, R; Gendrel, D, 2008) |
| " Blood levels of enrofloxacin and ciprofloxacin (enrofloxacin's active metabolite), were determined after either intramuscular or oral dosing of enrofloxacin for 7 days in a cross-over study." | 1.35 | A pharmacokinetic study of enrofloxacin and its active metabolite ciprofloxacin after oral and intramuscular dosing of enrofloxacin in rhesus monkeys (Macaca mulatta). ( Handt, L; Hasselschwert, D; Kastello, M; Klein, H, 2008) |
| "Nalidixic acid resistance was observed in 6/13 (46." | 1.32 | Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia. ( Al-Mulhim, K; Panhotra, BR; Saxena, AK, 2004) |
| "Two adults had "pseudomeningitis" syndromes, illustrating that shigellosis in adults may initially be misdiagnosed." | 1.29 | Epidemiologic and clinical aspects of shigellosis in American forces deployed to Saudi Arabia. ( Zajdowicz, T, 1993) |
| "We conclude that Shigella infection is associated with a protein-losing enteropathy, that this enteropathy is more severe with S." | 1.29 | Enteric protein loss during shigellosis. ( Bennish, ML; Salam, MA; Wahed, MA, 1993) |
| "A case of sporadic shigellosis is reported." | 1.28 | [Encephalopathy in an adult with Shigella]. ( Belnicoff, SA; Grassi, D, 1991) |
| "Twenty-two patients had a minor salmonellosis (13 S." | 1.28 | [Treatment of salmonellosis and shigellosis with the new quinolones]. ( Biron, F; Boibieux, A; Peyramond, D; Tigaud, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.00) | 18.7374 |
| 1990's | 27 (27.00) | 18.2507 |
| 2000's | 21 (21.00) | 29.6817 |
| 2010's | 36 (36.00) | 24.3611 |
| 2020's | 13 (13.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, RJ | 2 |
| Simpkin, AJ | 1 |
| Pulford, CV | 1 |
| Low, R | 1 |
| Rasko, DA | 1 |
| Rigden, DJ | 1 |
| Hall, N | 1 |
| Barry, EM | 1 |
| Tennant, SM | 2 |
| Baker, KS | 3 |
| Gaudreau, C | 3 |
| Bernaquez, I | 1 |
| Pilon, PA | 3 |
| Goyette, A | 1 |
| Yared, N | 1 |
| Bekal, S | 2 |
| Nuzhat, S | 3 |
| Das, R | 3 |
| Das, S | 3 |
| Islam, SB | 3 |
| Palit, P | 3 |
| Haque, MA | 3 |
| Chakraborty, S | 3 |
| Khan, SH | 3 |
| Ahmed, D | 4 |
| Alam, B | 3 |
| Ahmed, T | 3 |
| Chisti, MJ | 3 |
| Faruque, ASG | 3 |
| Lefèvre, S | 2 |
| Njamkepo, E | 1 |
| Feldman, S | 1 |
| Ruckly, C | 1 |
| Carle, I | 1 |
| Lejay-Collin, M | 1 |
| Fabre, L | 1 |
| Yassine, I | 1 |
| Frézal, L | 1 |
| Pardos de la Gandara, M | 1 |
| Fontanet, A | 1 |
| Weill, FX | 4 |
| Baharvand, A | 1 |
| Molaeipour, L | 1 |
| Alesaeidi, S | 1 |
| Shaddel, R | 1 |
| Mashatan, N | 1 |
| Amiriani, T | 1 |
| Kiaei Sudkolaei, M | 1 |
| Abbasian, S | 1 |
| Talib Al-Naqeeb, BZ | 1 |
| Kouhsari, E | 1 |
| Kasumba, IN | 1 |
| Badji, H | 1 |
| Powell, H | 1 |
| Hossain, MJ | 1 |
| Omore, R | 1 |
| Sow, SO | 1 |
| Verani, JR | 1 |
| Platts-Mills, JA | 1 |
| Widdowson, MA | 1 |
| Zaman, SMA | 1 |
| Jones, J | 1 |
| Sen, S | 1 |
| Permala-Booth, J | 1 |
| Nasrin, S | 1 |
| Roose, A | 1 |
| Nasrin, D | 1 |
| Ochieng, JB | 1 |
| Juma, J | 1 |
| Doh, S | 1 |
| Jones, JCM | 1 |
| Antonio, M | 1 |
| Awuor, AO | 1 |
| Sugerman, CE | 1 |
| Watson, N | 1 |
| Focht, C | 1 |
| Liu, J | 1 |
| Houpt, E | 1 |
| Kotloff, KL | 1 |
| McCloskey, MC | 1 |
| Shaheen, S | 1 |
| Rabago, L | 1 |
| Hulverson, MA | 1 |
| Choi, R | 1 |
| Barrett, LK | 1 |
| Arnold, SLM | 1 |
| Chung The, H | 3 |
| Boinett, C | 2 |
| Pham Thanh, D | 2 |
| Jenkins, C | 3 |
| Howden, BP | 2 |
| Valcanis, M | 3 |
| De Lappe, N | 3 |
| Cormican, M | 3 |
| Wangchuk, S | 2 |
| Bodhidatta, L | 3 |
| Mason, CJ | 2 |
| Nguyen, TNT | 1 |
| Ha Thanh, T | 2 |
| Voong, VP | 1 |
| Duong, VT | 1 |
| Nguyen, PHL | 1 |
| Turner, P | 2 |
| Wick, R | 1 |
| Ceyssens, PJ | 1 |
| Thwaites, G | 2 |
| Holt, KE | 4 |
| Thomson, NR | 4 |
| Rabaa, MA | 3 |
| Baker, S | 6 |
| Thanh Duy, P | 1 |
| Thi Nguyen, TN | 1 |
| Vu Thuy, D | 2 |
| Alcock, F | 1 |
| Dan Thanh, HN | 1 |
| Thanh Tuyen, H | 1 |
| Thwaites, GE | 1 |
| Shad, AA | 1 |
| Shad, WA | 1 |
| Muthuirulandi Sethuvel, DP | 1 |
| Mutreja, A | 1 |
| Pragasam, AK | 1 |
| Vasudevan, K | 1 |
| Murugan, D | 1 |
| Anandan, S | 1 |
| Michael, JS | 1 |
| Walia, K | 1 |
| Veeraraghavan, B | 1 |
| Hawkey, J | 1 |
| Paranagama, K | 1 |
| Cerdeira, L | 1 |
| Iqbal, Z | 1 |
| Hunt, M | 1 |
| Ingle, DJ | 1 |
| Dallman, TJ | 2 |
| Williamson, DA | 1 |
| Gharpure, R | 1 |
| Friedman, CR | 1 |
| Fialkowski, V | 1 |
| Collins, JP | 1 |
| Strysko, J | 1 |
| Marsh, ZA | 1 |
| Chen, JC | 1 |
| Meservey, EH | 1 |
| Adediran, AA | 1 |
| Schroeder, MN | 1 |
| Wadhwa, A | 1 |
| Fullerton, KE | 1 |
| Francois Watkins, L | 1 |
| Moreno-Mingorance, A | 1 |
| Espinal, P | 1 |
| Rodriguez, V | 1 |
| Goterris, L | 1 |
| Fàbrega, A | 1 |
| Serra-Pladevall, J | 1 |
| Barberà, MJ | 1 |
| Alberny, M | 1 |
| Martín-González, H | 1 |
| Cornejo-Sánchez, T | 1 |
| Armas, M | 1 |
| Mir-Cros, A | 1 |
| Raventós, A | 1 |
| Viñado, B | 1 |
| Pumarola, T | 1 |
| Larrosa, MN | 1 |
| González-López, JJ | 1 |
| Pouofo Nguiam, M | 1 |
| Njonte Wouamba, SC | 1 |
| Longo, F | 1 |
| Gounoue Kamkumo, R | 1 |
| Donji Kenne Foweda, L | 1 |
| Dzeufiet Djomeni, PD | 1 |
| Lenta Ndjakou, B | 1 |
| Sewald, N | 1 |
| Fekam Boyom, F | 1 |
| Kouam Fogue, S | 1 |
| Dimo, T | 1 |
| Dhital, S | 1 |
| Sherchand, JB | 1 |
| Pokharel, BM | 1 |
| Parajuli, K | 1 |
| Mishra, SK | 1 |
| Sharma, S | 1 |
| Kattel, HP | 1 |
| Khadka, S | 1 |
| Khatiwada, S | 1 |
| Rijal, B | 1 |
| Zhu, Z | 1 |
| Zhou, X | 1 |
| Li, B | 1 |
| Wang, S | 1 |
| Cheng, F | 1 |
| Zhang, J | 1 |
| Brown, JD | 1 |
| Willcox, SJ | 1 |
| Franklin, N | 1 |
| Hazelton, B | 1 |
| Howard, P | 1 |
| Reinten, T | 1 |
| Sheppeard, V | 1 |
| O'Sullivan, M | 1 |
| Field, N | 1 |
| Childs, T | 1 |
| Mitchell, H | 1 |
| Day, M | 1 |
| Tourdjman, M | 1 |
| Hughes, G | 1 |
| Thomson, N | 1 |
| Pu, XY | 2 |
| Gu, Y | 1 |
| Li, J | 3 |
| Song, SJ | 1 |
| Lu, Z | 1 |
| Khademi, F | 1 |
| Sahebkar, A | 1 |
| Zhu, YL | 1 |
| Yang, HF | 1 |
| Liu, YY | 1 |
| Hu, LF | 1 |
| Cheng, J | 1 |
| Ye, Y | 1 |
| Li, JB | 1 |
| Thieu Nga, TV | 1 |
| Thanh, DP | 1 |
| Vinh, H | 2 |
| Kim, DW | 1 |
| Vu Tra, MP | 1 |
| Campbell, JI | 2 |
| Hoang, NV | 2 |
| Vinh, NT | 1 |
| Minh, PV | 2 |
| Thuy, CT | 2 |
| Nga, TT | 1 |
| Thompson, C | 1 |
| Dung, TT | 1 |
| Nhu, NT | 2 |
| Vinh, PV | 1 |
| Tuyet, PT | 1 |
| Phuc, HL | 1 |
| Lien, NT | 1 |
| Phu, BD | 1 |
| Ai, NT | 1 |
| Tien, NM | 1 |
| Dong, N | 1 |
| Parry, CM | 1 |
| Hien, TT | 1 |
| Farrar, JJ | 2 |
| Parkhill, J | 1 |
| Dougan, G | 1 |
| Ud-Din, AI | 1 |
| Wahid, SU | 1 |
| Latif, HA | 1 |
| Shahnaij, M | 1 |
| Akter, M | 1 |
| Azmi, IJ | 1 |
| Hasan, TN | 1 |
| Hossain, MA | 2 |
| Faruque, AS | 1 |
| Faruque, SM | 1 |
| Talukder, KA | 2 |
| Zhang, CL | 1 |
| Liu, QZ | 1 |
| Wang, J | 1 |
| Chu, X | 1 |
| Shen, LM | 1 |
| Guo, YY | 1 |
| Schofield, DA | 1 |
| Wray, DJ | 1 |
| Molineux, IJ | 1 |
| Bowen, A | 1 |
| Hurd, J | 1 |
| Hoover, C | 1 |
| Khachadourian, Y | 1 |
| Traphagen, E | 1 |
| Harvey, E | 1 |
| Libby, T | 1 |
| Ehlers, S | 1 |
| Ongpin, M | 1 |
| Norton, JC | 1 |
| Bicknese, A | 1 |
| Kimura, A | 1 |
| Sangeetha, AV | 1 |
| Parija, SC | 2 |
| Mandal, I | 1 |
| Krishnamurthy, S | 1 |
| O'Connor, J | 1 |
| Garvey, P | 1 |
| McKeown, P | 1 |
| Allam, NG | 1 |
| Eldrieny, EA | 1 |
| Mohamed, AZ | 1 |
| Kim, JS | 1 |
| Kim, JJ | 1 |
| Kim, SJ | 1 |
| Jeon, SE | 1 |
| Seo, KY | 1 |
| Choi, JK | 1 |
| Kim, NO | 1 |
| Hong, S | 1 |
| Chung, GT | 1 |
| Yoo, CK | 1 |
| Kim, YT | 1 |
| Cheun, HI | 1 |
| Bae, GR | 1 |
| Yeo, YH | 1 |
| Ha, GJ | 1 |
| Choi, MS | 1 |
| Kang, SJ | 1 |
| Kim, J | 1 |
| Harrington, R | 1 |
| Pan, JC | 1 |
| Gu, YM | 1 |
| Zheng, W | 1 |
| Yu, H | 1 |
| Lübbert, C | 1 |
| Rocha-Castro, J | 1 |
| Kronbauer, K | 1 |
| Dallé, J | 1 |
| Jimenez, MF | 1 |
| Riche, CW | 1 |
| Santiago, JA | 1 |
| Antonello, VS | 1 |
| Lane, CR | 1 |
| Sutton, B | 1 |
| Kirk, M | 1 |
| Walker, C | 1 |
| Lalor, K | 1 |
| Stephens, N | 1 |
| Chiou, CS | 1 |
| Izumiya, H | 1 |
| Kawamura, M | 1 |
| Liao, YS | 1 |
| Su, YS | 1 |
| Wu, HH | 1 |
| Chen, WC | 1 |
| Lo, YC | 1 |
| Goulart, MA | 1 |
| Wurcel, AG | 1 |
| Nguyen Thi Nguyen, T | 1 |
| Thompson, CN | 1 |
| Phu Huong Lan, N | 1 |
| Voong Vinh, P | 1 |
| Sar, P | 1 |
| Das, A | 1 |
| Natarajan, M | 1 |
| Mandal, J | 1 |
| Cornut, G | 1 |
| Marchand-Senecal, X | 1 |
| Dhodapkar, R | 1 |
| Acharya, NS | 1 |
| Harish, BN | 1 |
| Gendrel, D | 1 |
| Cohen, R | 1 |
| Rabbani, GH | 1 |
| Ahmed, S | 1 |
| Hossain, I | 1 |
| Islam, R | 1 |
| Marni, F | 1 |
| Akhtar, M | 1 |
| Majid, N | 1 |
| Franco, AI | 1 |
| Ortiz, J | 1 |
| Cabello, N | 1 |
| Ruiz Giardin, JM | 1 |
| Ruiz, JM | 1 |
| García, MI | 1 |
| Traa, BS | 1 |
| Walker, CL | 1 |
| Munos, M | 1 |
| Black, RE | 1 |
| Rosewell, A | 1 |
| Dagina, R | 1 |
| Murhekar, M | 1 |
| Ropa, B | 1 |
| Posanai, E | 1 |
| Dutta, S | 1 |
| Barr, I | 1 |
| Mola, G | 1 |
| Zwi, A | 1 |
| MacIntyre, CR | 1 |
| Anh, VT | 1 |
| Anh, ND | 1 |
| Nga, TV | 1 |
| Duy, PT | 1 |
| Phuong, le T | 1 |
| Loan, HT | 1 |
| Chinh, MT | 1 |
| Thao, NT | 1 |
| Tham, NT | 1 |
| Mong, BL | 1 |
| Bay, PV | 1 |
| Day, JN | 1 |
| Dolecek, C | 1 |
| Lan, NP | 1 |
| Diep, TS | 1 |
| Chau, NV | 1 |
| Wolbers, M | 1 |
| Zhang, W | 1 |
| Luo, Y | 1 |
| Lin, L | 1 |
| Ma, Y | 1 |
| Hu, C | 1 |
| Jin, S | 1 |
| Ran, L | 1 |
| Cui, S | 1 |
| Ratnayake, R | 1 |
| Gagnon, S | 1 |
| Roger, M | 1 |
| Lévesque, S | 1 |
| Gu, B | 1 |
| Cao, Y | 1 |
| Pan, S | 1 |
| Zhuang, L | 1 |
| Yu, R | 1 |
| Peng, Z | 1 |
| Qian, H | 1 |
| Wei, Y | 1 |
| Zhao, L | 1 |
| Liu, G | 1 |
| Tong, M | 1 |
| Orr, D | 1 |
| Hedderwick, S | 1 |
| Guerin, PJ | 2 |
| Brasher, C | 2 |
| Baron, E | 2 |
| Mic, D | 2 |
| Grimont, F | 2 |
| Ryan, M | 2 |
| Aavitsland, P | 2 |
| Legros, D | 3 |
| Ergönül, O | 1 |
| Imre, A | 1 |
| Celikbaş, A | 1 |
| Dokuzoğuz, B | 1 |
| Jones, FR | 1 |
| Sanchez, JL | 3 |
| Meza, R | 1 |
| Batsel, TM | 1 |
| Burga, R | 1 |
| Canal, E | 1 |
| Block, K | 1 |
| Perez, J | 1 |
| Bautista, CT | 1 |
| Escobedo, J | 1 |
| Walz, SE | 1 |
| Panhotra, BR | 1 |
| Saxena, AK | 1 |
| Al-Mulhim, K | 1 |
| Khajanchi, BK | 1 |
| Islam, MA | 1 |
| Dutta, DK | 1 |
| Islam, Z | 1 |
| Safa, A | 1 |
| Khan, GY | 1 |
| Alam, K | 1 |
| Malla, S | 1 |
| Niyogi, SK | 1 |
| Rahman, M | 2 |
| Watanabe, H | 1 |
| Nair, GB | 2 |
| Sack, DA | 2 |
| Hiranrattana, A | 1 |
| Mekmullica, J | 1 |
| Chatsuwan, T | 1 |
| Pancharoen, C | 1 |
| Thisyakorn, U | 1 |
| Taneja, N | 2 |
| Lyngdoh, VW | 1 |
| Sharma, M | 1 |
| Shoma, S | 1 |
| Rashid, H | 1 |
| El Arifeen, S | 1 |
| Baqui, AH | 1 |
| Siddique, AK | 1 |
| Acikgoz, ZC | 1 |
| Eser, OK | 1 |
| Kocagöz, S | 1 |
| Klein, H | 1 |
| Hasselschwert, D | 1 |
| Handt, L | 1 |
| Kastello, M | 1 |
| Soares, JL | 1 |
| Arendt, V | 1 |
| Coue, JC | 1 |
| Milleliri, JM | 1 |
| Philips, B | 1 |
| Regis, R | 1 |
| Mérouze, F | 1 |
| Rey, JL | 1 |
| Kaminski, N | 1 |
| Bogomolski, V | 1 |
| Stalnikowicz, R | 1 |
| Jiang, SC | 1 |
| Wang, XF | 1 |
| Miao, JZ | 1 |
| Bennish, ML | 5 |
| Salam, MA | 5 |
| Wahed, MA | 1 |
| Sethabutr, O | 1 |
| Venkatesan, M | 1 |
| Murphy, GS | 3 |
| Eampokalap, B | 1 |
| Hoge, CW | 2 |
| Echeverria, P | 4 |
| Tansuphaswadikul, S | 1 |
| Imlarp, S | 1 |
| Tamura, K | 1 |
| Zajdowicz, T | 1 |
| Dryden, MS | 1 |
| Gabb, RJ | 1 |
| Wright, SK | 1 |
| Khan, WA | 3 |
| Seas, C | 1 |
| Dhar, U | 2 |
| Kuijper, EJ | 1 |
| van Eeden, A | 1 |
| de Wever, B | 1 |
| van Ketel, R | 1 |
| Dankert, J | 1 |
| Sidorenko, SV | 1 |
| Paquet, C | 1 |
| Dorlencourt, F | 1 |
| Saoult, E | 1 |
| Baiulescu, M | 1 |
| Hannon, PR | 1 |
| Marcinak, JF | 1 |
| Janda, WM | 1 |
| Schreckenberger, PC | 1 |
| Nelson, MR | 2 |
| Shanson, DC | 2 |
| Hawkins, DA | 1 |
| Gazzard, BG | 2 |
| Khan, AM | 1 |
| Bhattacharya, SK | 1 |
| Bhattacharya, MK | 1 |
| Dutta, D | 1 |
| Dutta, P | 1 |
| Paul, M | 1 |
| Sen, D | 1 |
| Sarkar, S | 1 |
| Saha, A | 1 |
| Pal, SC | 1 |
| Petruccelli, BP | 1 |
| Walz, S | 1 |
| DeFraites, R | 1 |
| Gelnett, J | 1 |
| Haberberger, RL | 1 |
| Taylor, DN | 2 |
| Hawkins, D | 1 |
| Belnicoff, SA | 1 |
| Grassi, D | 1 |
| Williams, HM | 1 |
| Richards, J | 1 |
| Candler, W | 1 |
| Thornton, S | 1 |
| McQueen, C | 1 |
| Mashilov, VP | 1 |
| Avdeeva, LA | 1 |
| Kaluzhina, TI | 1 |
| Brodov, LE | 1 |
| Golokhvastova, EL | 1 |
| Iakovleva, ON | 1 |
| Alikeeva, GK | 1 |
| Goodman, LJ | 1 |
| Trenholme, GM | 1 |
| Kaplan, RL | 1 |
| Segreti, J | 1 |
| Hines, D | 1 |
| Petrak, R | 1 |
| Nelson, JA | 1 |
| Mayer, KW | 1 |
| Landau, W | 1 |
| Parkhurst, GW | 1 |
| Haider, R | 1 |
| Barza, M | 1 |
| O'Riordan, T | 1 |
| Kavanagh, P | 1 |
| Mellotte, G | 1 |
| Conneally, E | 1 |
| Mulvihill, E | 1 |
| Keogh, JA | 1 |
| Moráin, CO | 1 |
| Biron, F | 1 |
| Boibieux, A | 1 |
| Tigaud, S | 1 |
| Peyramond, D | 1 |
| Hamer, IE | 1 |
| Olczak, SA | 1 |
| Parkin, D | 1 |
| Pichler, H | 1 |
| Diridl, G | 2 |
| Wolf, D | 2 |
| Imagawa, Y | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Ito, K | 1 |
| Matsubara, Y | 1 |
| Seo, T | 1 |
| Sagara, H | 1 |
| Tagawa, K | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Pichler, HE | 1 |
| Stickler, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Incidence and Burden of Shigella Diarrhea in Children Aged 6-35 Months: the Enterics for Global Health (EFGH) - Shigella Burden Study[NCT06047821] | 9,800 participants (Anticipated) | Observational | 2022-08-25 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ciprofloxacin and Dysentery, Shiga bacillus
| Article | Year |
|---|---|
The increasing antimicrobial resistance of
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bac | 2023 |
Shigella sonnei: virulence and antibiotic resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Escherichia | 2021 |
Fluoroquinolones-resistant Shigella species in Iranian children: a meta-analysis.
Topics: Child; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Fluoroquinolones; Humans; Ir | 2019 |
Antimicrobial therapy of acute diarrhoea: a clinical review.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campyloba | 2016 |
Antibiotics for the treatment of dysentery in children.
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Dysentery | 2010 |
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.
Topics: Africa; Americas; Anti-Bacterial Agents; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, | 2012 |
[Ciprofloxacin in the treatment of intestinal infections of bacterial etiology].
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Dysentery, B | 1997 |
17 trials available for ciprofloxacin and Dysentery, Shiga bacillus
| Article | Year |
|---|---|
Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial.
Topics: Anti-Bacterial Agents; Carbohydrates; Child, Preschool; Ciprofloxacin; Double-Blind Method; Dysenter | 2009 |
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Dysentery, Bacillary; Feces; Female; Fluoroq | 2011 |
Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
Topics: Administration, Oral; Child; Child, Preschool; Ciprofloxacin; Confidence Intervals; Dose-Response Re | 2002 |
[Short-term ciprofloxacin treatment of bacillary dysentery due to Shigella dysenteriae type 1 in Rwandan refugees].
Topics: Adult; Ciprofloxacin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; | 1994 |
[Clinical efficacy of ciprofloxacin and ofloxacin].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Dysentery, Bacillary; Female; Gonorrhe | 1994 |
Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
Topics: Adult; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary | 1993 |
Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.
Topics: Adult; Age Factors; Aged; Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Community- | 1996 |
Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Double | 1997 |
Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
Topics: Adolescent; Amdinocillin Pivoxil; Anti-Infective Agents; Arthralgia; Child; Child, Preschool; Ciprof | 1998 |
Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial.
Topics: Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Dysentery, Bacillary; Follo | 1992 |
Treatment of traveler's diarrhea with ciprofloxacin and loperamide.
Topics: Campylobacter Infections; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; D | 1992 |
Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial.
Topics: Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary; Esche | 1991 |
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.
Topics: Adult; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Diarrhea; | 1990 |
Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.
Topics: Adult; Ampicillin; Ampicillin Resistance; Ciprofloxacin; Double-Blind Method; Dysentery, Bacillary; | 1990 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
[Comparison of clinical efficacy of ciprofloxacin (CPFX, BAY o 9867) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Ciprofloxacin, Research Group for Infectious Enteritis].
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Dysentery, Ba | 1988 |
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; | 1987 |
76 other studies available for ciprofloxacin and Dysentery, Shiga bacillus
| Article | Year |
|---|---|
Pathogenomic analyses of Shigella isolates inform factors limiting shigellosis prevention and control across LMICs.
Topics: Child; Child, Preschool; Ciprofloxacin; Developing Countries; Drug Resistance, Bacterial; Dysentery, | 2022 |
Clinical and Genomic Investigation of an International Ceftriaxone- and Azithromycin-Resistant Shigella sonnei Cluster among Men Who Have Sex with Men, Montréal, Canada 2017-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Dysente | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Rapid emergence of extensively drug-resistant Shigella sonnei in France.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bact | 2023 |
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diarrhea; | 2023 |
Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Disease Models, Animal; Dysent | 2019 |
Dissecting the molecular evolution of fluoroquinolone-resistant Shigella sonnei.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Asia, Western; Bayes Theorem; Ciprofloxacin; Directed Mol | 2019 |
Commensal Escherichia coli are a reservoir for the transfer of XDR plasmids into epidemic fluoroquinolone-resistant Shigella sonnei.
Topics: Child; Ciprofloxacin; Digestive System; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Dy | 2020 |
Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Ev | 2020 |
Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; | 2021 |
Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; D | 2022 |
Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Disease Susceptibility; Drug Resistance, | 2021 |
Antibacterial and antishigellosis activity of Xylopia staudtii (engl. & diels), Annonaceae.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cameroon; Chromatography, High Pressure Li | 2021 |
Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production.
Topics: Anti-Infective Agents; beta-Lactamases; Cefixime; Child; Child, Preschool; Ciprofloxacin; Drug Resis | 2017 |
Genomic Analysis and Resistance Mechanisms in Shigella flexneri 2a Strain 301.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Computational Biology; DNA, Bacterial; DNA, Inter | 2018 |
Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Australia; Azithromycin; Child; Child, Preschool; Ci | 2017 |
Genomic epidemiology of Shigella in the United Kingdom shows transmission of pathogen sublineages and determinants of antimicrobial resistance.
Topics: Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Phylogeny; Shigel | 2018 |
Characterization of the complete sequences and stability of plasmids carrying the genes aac(6')-Ib-cr or qnrS in Shigella flexneri in the Hangzhou area of China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; China; Chromosome Mapping; Ciprofloxacin; | 2018 |
Detection of plasmid-mediated quinolone resistance determinants and the emergence of multidrug resistance in clinical isolates of Shigella in SiXian area, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Ciprofloxacin; DNA Gyrase; DNA To | 2013 |
Tracking the establishment of local endemic populations of an emergent enteric pathogen.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Chromosomes, Bacterial; Ciprofloxacin; Dysentery, Ba | 2013 |
Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Multipl | 2013 |
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cepha | 2014 |
Isolation and development of bioluminescent reporter phages for bacterial dysentery.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriophages; Ciprofloxacin; DNA, Viral; Dysentery, Bacillary; | 2015 |
Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin - United States, May 2014-February 2015.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; Disease Outbreaks; Drug Resistance, B | 2015 |
Clinical and microbiological profiles of shigellosis in children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacteri | 2014 |
Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; | 2015 |
Effect of combination therapy between thyme oil and ciprofloxacin on ulcer-forming Shigella flexneri.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Ciprofloxacin; Colitis, Ulcerative; Colon; Drug Syne | 2015 |
Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, Republic of Korea.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Child; Child, Preschool; Ciprofloxacin; D | 2015 |
Drug-Resistant Stomach Bug.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Shigella sonnei; United Sta | 2015 |
Complete Sequences and Characterization of Two Novel Plasmids Carrying aac(6')-Ib-cr and qnrS Gene in Shigella flexneri.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; China; Ciprofloxacin; Con | 2016 |
Travelers Spreading a Multidrug-Resistant Bacteria to the United States.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Shig | 2015 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sect | 2016 |
Travel Destinations and Sexual Behavior as Indicators of Antibiotic Resistant Shigella Strains--Victoria, Australia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Child; Chi | 2016 |
The worldwide spread of ciprofloxacin-resistant Shigella sonnei among HIV-infected men who have sex with men, Taiwan.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Disease Outbreaks; Disease Transm | 2016 |
Shigellosis in men who have sex with men: an overlooked opportunity to counsel with pre-exposure prophylaxis for HIV.
Topics: Adult; Ciprofloxacin; Dysentery, Bacillary; HIV Infections; Homosexuality, Male; Humans; Male; Pre-E | 2016 |
South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant Shigella sonnei: A Cross-Sectional Study.
Topics: Anti-Bacterial Agents; Australia; Bhutan; Cambodia; Child, Preschool; Ciprofloxacin; Cross-Sectional | 2016 |
The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bac | 2016 |
Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Ciprofloxacin; Coinfection; Drug Resistance, Bacterial; | 2016 |
Shigellosis in Puducherry.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, B | 2008 |
[Bacterial diarrheas and antibiotics: European recommendations].
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter j | 2008 |
[Shigella bacteremia dysentery in an adult].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Dysentery, Bacillary; Female; Humans; Microb | 2010 |
Concurrent influenza and shigellosis outbreaks, Papua New Guinea, 2009.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Disease | 2011 |
Wide dissemination of multidrug-resistant Shigella isolates in China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Cephalosporins; | 2011 |
Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010.
Topics: Adult; Aged; Anti-Bacterial Agents; Canada; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacte | 2011 |
Shigella flexneri bacteraemia in an immunocompetent male treated with oral ciprofloxacin.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Dysentery, Bacillary; | 2002 |
Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone.
Topics: Anti-Infective Agents; Ciprofloxacin; Disease Outbreaks; Dysentery, Bacillary; Humans; Serotyping; S | 2003 |
Drug resistance of Shigella species: changes over 20 years in Turkey.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biological Evolution; Ceftriaxone; Chloramphenicol; | 2004 |
Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, B | 2004 |
Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacte | 2004 |
Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asia; Ciprofloxacin; Disease Outbreaks; DNA Fingerpr | 2004 |
Case management of a multidrug-resistant Shigella dysenteriae serotype 1 outbreak in a crisis context in Sierra Leone, 1999-2000.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Animals; Anti-Infective Agents; Child; | 2004 |
Antibiotics in the management of shigellosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Hu | 2004 |
International note. Antibiotics in the management of shigellosis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, | 2004 |
Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996-2000).
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Infective Agents; Cefazolin; Child; Child, Preschool; | 2005 |
Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacil | 2005 |
Emergence of quinolone-resistant Shigella dysenteriae type 1 in Canada.
Topics: Adult; Alberta; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Fluoroquinolones; H | 2005 |
Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacil | 2007 |
Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Azithromycin; Bangladesh; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial | 2007 |
CTX-M-3 type beta-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases.
Topics: Anti-Infective Agents; beta-Lactamases; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Mul | 2008 |
A pharmacokinetic study of enrofloxacin and its active metabolite ciprofloxacin after oral and intramuscular dosing of enrofloxacin in rhesus monkeys (Macaca mulatta).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Chromatography; Ciprofloxacin; Cross-Over Stud | 2008 |
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bacteri | 1994 |
Enteric protein loss during shigellosis.
Topics: Adult; alpha 1-Antitrypsin; Ampicillin; Blood Proteins; Ciprofloxacin; Drug Resistance, Microbial; D | 1993 |
Detection of Shigellae and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery.
Topics: Antigens, Bacterial; Bacterial Proteins; Base Sequence; Ciprofloxacin; DNA Probes; DNA, Bacterial; D | 1993 |
Epidemiologic and clinical aspects of shigellosis in American forces deployed to Saudi Arabia.
Topics: Adult; Ciprofloxacin; Dysentery, Bacillary; Fluid Therapy; Humans; Male; Meningism; Military Personn | 1993 |
Nonserotypeable Shigella dysenteriae isolated from a Dutch patient returning from India.
Topics: Anti-Infective Agents; Ciprofloxacin; Dysentery, Bacillary; Humans; India; Male; Middle Aged; Nether | 1997 |
Risk factors for death in hospitalized dysentery patients in Rwanda.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Dysentery, Bacillary; Female; Hospitalizati | 1999 |
Chronic vulvovaginitis caused by antibiotic-resistant Shigella flexneri in a prepubertal child.
Topics: Anti-Infective Agents; Child; Chronic Disease; Ciprofloxacin; Drug Resistance; Dysentery, Bacillary; | 2002 |
Salmonella, Campylobacter and Shigella in HIV-seropositive patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Campylobacter Infections; CD4-Positive T-Lymphoc | 1992 |
Single-dose ciprofloxacin for shigellosis in adults.
Topics: Adolescent; Adult; Ciprofloxacin; Dysentery, Bacillary; Humans; India; Shigella dysenteriae; Shigell | 1992 |
Shigella in HIV infection.
Topics: Adult; Ciprofloxacin; Dysentery, Bacillary; Feces; HIV Infections; Humans; Male; Opportunistic Infec | 1991 |
[Encephalopathy in an adult with Shigella].
Topics: Adult; Ciprofloxacin; Dysentery, Bacillary; Encephalitis; Female; Humans | 1991 |
Single-dose ciprofloxacin for shigellosis.
Topics: Ciprofloxacin; Cross Infection; Disease Outbreaks; Dysentery, Bacillary; Female; Humans; Shigella so | 1990 |
[Experience in using new drug preparations for treating adult patients with acute intestinal infections].
Topics: Acute Disease; Adult; Anti-Infective Agents, Local; Carrier State; Ciprofloxacin; Drug Combinations; | 1990 |
Haemolytic uraemic syndrome with shigella.
Topics: Cefuroxime; Ciprofloxacin; Diagnosis, Differential; Dysentery, Bacillary; Fluid Therapy; Hemolytic-U | 1990 |
[Treatment of salmonellosis and shigellosis with the new quinolones].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Dysentery, Bacillary; Female; Huma | 1990 |
Mixed enteric infection.
Topics: Adult; Campylobacter Infections; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Egypt; Female; Human | 1990 |